Back to List
Sookjin Lee
Chief Business Officer (CBO) | Ph.D.
A business expert leading innovation in precision medicine and genomics for 20 years. Accelerating the commercialization of innovative technologies with academic expertise and market insight.
Negative Genetic Test Result: What to Say to Your Patient
Product | 26. 07. 28
Hypochondroplasia vs. Achondroplasia: What Distinguishes Them
Rare disease series | 26. 07. 27
Achondroplasia in Children: From the FGFR3 Mutation to Voxzogo, the First Targeted Therapy
Rare disease series | 26. 07. 24
Solving Undiagnosed Cases with Long-Read Sequencing (Part 1): Finding the Missing Variant in Autosomal Recessive Disease
Insights | 26. 07. 22
ICD-10 Metabolic Encephalopathy: What the Code G93.41 Means
Rare disease series | 26. 07. 14
Reproductive Genetic Carrier Screening (RGCS): When and Who to Recommend It To — A Clinical Guide from 5 Year Outcome Data
Insights | 26. 07. 02
